Global Reusable Endoscopic Vessel Harvesting Products Market Size By Type (EVH Systems, Endoscopes), By Application (Coronary Artery Disease, Peripheral Artery Disease), By Region, And Segment Forecas...

The Global Reusable Endoscopic Vessel Harvesting Products Market was valued at USD 421 million in 2023 and is projected to reach USD 692 million by 2031, expanding at a CAGR of 6.6% during the forecast period of 2023–2031. This growth is primarily fueled by the increasing number of coronary artery bypass graft (CABG) procedures, the growing preference for minimally invasive surgeries, and the cost-efficiency of reusable instruments over disposable ones. As hospitals seek to reduce procedural costs without compromising patient safety or surgical efficacy, reusable endoscopic vessel harvesting (EVH) systems are becoming a preferred choice in cardiac procedures globally.

Drivers:

1. Rising Incidence of Cardiovascular Diseases:

The global burden of cardiovascular diseases continues to escalate, leading to a higher volume of CABG surgeries, a key driver for the demand of reusable EVH products.

2. Cost-Efficiency of Reusable Devices:

Compared to single-use alternatives, reusable EVH systems reduce per-procedure cost in the long term, especially beneficial for high-volume surgical centers.

3. Growing Adoption of Minimally Invasive Techniques:

Surgeons and healthcare facilities are increasingly favoring minimally invasive methods that offer faster recovery times, reduced scarring, and lower infection risks, all of which are enabled by EVH techniques.

Restraints:

1. High Initial Investment:

Although reusable devices reduce recurring costs, their upfront acquisition and sterilization infrastructure requirements can be prohibitive for smaller or resource-limited hospitals.

2. Sterilization and Maintenance Challenges:

Maintaining the sterility and functional integrity of reusable EVH tools over multiple uses requires strict adherence to protocols, which may deter some facilities due to logistical constraints.

Opportunity:

1. Emerging Market Penetration:

Rising investments in healthcare infrastructure across Asia-Pacific and Latin America offer untapped potential for reusable EVH systems, especially in countries focusing on lowering long-term surgical expenditures.

2. Technological Innovations in Reusable Systems:

Improvements in material science and ergonomics are making newer generations of reusable EVH products more durable, easier to handle, and compatible with advanced visualization systems.

Market by System Type Insights:

By system type, endoscopic vein harvesting systems dominated the market in 2023. These systems are essential in CABG surgeries and have shown strong adoption due to their proven clinical efficacy. The endoscopic radial artery harvesting segment is also gaining traction as radial artery grafting increases globally due to favorable patency rates.

Market by End-use Insights:

The hospital segment accounted for the largest revenue share in 2023. Tertiary care centers and cardiac specialty hospitals are the primary users of reusable EVH products due to their capability to invest in sterilization infrastructure and high procedure volumes. The ambulatory surgical centers segment is projected to grow rapidly due to the shift toward outpatient cardiovascular interventions in developed markets.

Market by Regional Insights:

North America held the largest market share in 2023, owing to its advanced healthcare infrastructure, high rate of CABG procedures, and favorable reimbursement frameworks. Asia-Pacific is anticipated to register the highest CAGR during the forecast period, driven by the growing prevalence of cardiovascular diseases, increasing awareness of cost-effective surgical tools, and governmental support for healthcare modernization.

Competitive Scenario:

Key players in the Global Reusable Endoscopic Vessel Harvesting Products Market include Getinge AB, Terumo Corporation, Karl Storz SE & Co. KG, Med Europe S.r.l., Saphena Medical, Inc., and B. Braun Melsungen AG. These companies focus on product development, clinical validation, and strategic partnerships to expand their portfolios and geographic footprint.

Key Market Developments:

2023: Saphena Medical launched an ergonomically redesigned reusable EVH system aimed at reducing surgeon fatigue and enhancing vessel visualization.

2024: Getinge AB announced its partnership with a chain of European cardiovascular centers to deploy its next-gen reusable harvesting platforms.

2025: Terumo Corporation initiated a clinical trial to validate the performance of its hybrid reusable-disposable EVH solution designed for cost-sensitive markets.

Scope of Work – Global Reusable Endoscopic Vessel Harvesting Products Market

FAQs:

1) What is the current market size of the Global Reusable Endoscopic Vessel Harvesting Products Market?

The market was valued at USD 421 million in 2023.

2) What is the major growth driver of the Global Reusable Endoscopic Vessel Harvesting Products Market?

The major driver is the rising number of CABG surgeries and the growing shift toward cost-effective and minimally invasive surgical procedures.

3) Which is the largest region during the forecast period in the Global Reusable Endoscopic Vessel Harvesting Products Market?

North America is projected to remain the largest region throughout the forecast period.

4) Which segment accounted for the largest market share in the Global Reusable Endoscopic Vessel Harvesting Products Market?

The endoscopic vein harvesting system segment held the largest market share in 2023.

5) Who are the key market players in the Global Reusable Endoscopic Vessel Harvesting Products Market?

Key players include Getinge AB, Terumo Corporation, Karl Storz SE & Co. KG, Med Europe S.r.l., Saphena Medical, Inc., and B. Braun Melsungen AG.